XML 20 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Unaudited Interim Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Operating Activities    
Net earnings (loss) $ 538 $ 813
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities    
Asset impairments 31 83
Depreciation, amortization and accretion 265 265
Pension and postretirement net periodic benefit cost (74) (44)
Pension and postretirement contributions (35) (35)
Deferred income taxes, net (90) (21)
(Gain) loss on disposition of businesses and assets, net 1 2
Stock-based compensation 17 38
Undistributed earnings in unconsolidated affiliates (2) (8)
Other, net 15 15
Operating cash provided by (used in) discontinued operations 7 5
Changes in operating assets and liabilities    
Trade receivables - third party and affiliates, net 196 55
Inventories 78 34
Other assets 68 (36)
Trade payables - third party and affiliates (57) (44)
Other liabilities 111 6
Net cash provided by (used in) operating activities 1,069 1,128
Investing Activities    
Capital expenditures on property, plant and equipment (279) (226)
Acquisitions, net of cash acquired (100) (91)
Proceeds from sale of businesses and assets, net 17 1
Other, net (25) (9)
Net cash provided by (used in) investing activities (387) (325)
Financing Activities    
Net change in short-term borrowings with maturities of 3 months or less 170 127
Proceeds from short-term borrowings 306 110
Repayments of short-term borrowings (452) (85)
Proceeds from long-term debt 0 (499)
Repayments of long-term debt (23) (354)
Purchases of treasury stock, including related fees (272) (763)
Common stock dividends (221) (225)
Distributions to noncontrolling interests (21) (7)
Other, net (25) (38)
Net cash provided by (used in) financing activities (538) (736)
Exchange rate effects on cash and cash equivalents 8 (9)
Net increase (decrease) in cash and cash equivalents 152 58
Cash and cash equivalents as of beginning of period 463 439
Cash and cash equivalents as of end of period $ 615 $ 497